Screening for hepatitis B surface antigen before chemotherapy: Current practice and opportunities for improvement

Current Oncology

Volumn 17, Issue 6, 2010, Pages 32-38

  Lee, R ^a   Vu, K ^b   Bell, C M ^a,b,c   Hick, L K ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Hepatitis b reactivation; Quality assurance

Indexed keywords

ANTHRACYCLINE; HEPATITIS B SURFACE ANTIGEN; TRASTUZUMAB;

ADULT; AWARENESS; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL PRACTICE; FEMALE; HEALTH CARE PERSONNEL; HEART LEFT VENTRICLE FUNCTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INTERVIEW; MALE; MEDICAL RECORD REVIEW; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SCREENING; SOLID TUMOR; VIRUS REACTIVATION;

EID: 78650137009     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v17i6.653     Document Type: Review

References (23)

1. Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 2003;39(suppl 1):S64-9.
2. Yeo W, Ho WM, Hui P, et al. Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients. Breast Cancer Res Treat 2004;88:209-15.
3. Dai MS, Wu PF, Shyu RF, Lu JJ, Chao TY. Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration. Liver Int 2004;24:540-6.
4. Yeo W, Lam KC, Zee B, et al. Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy. Ann Oncol 2004;15:1661-6.
5. Yeo W, Hui EP, Chan AT, et al. Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine. Am J Clin Oncol 2005;28:379-84.
6. Cheng AL, Hsiung CA, Su IJ, et al. Steroid-free chemotherapy decreases risk of hepatitis B virus (h b v) reactivation in h bv -carriers with lymphoma. Hepatology 2003;37:1320-8.
7. Liang R, Lau GKK, Kwong YL. Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem. J Clin Oncol 1999;17:394-8.
8. Silvestri F, Ermacora A, Sperotto A, et al. Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation. Br J Haematol 2000;108:394-6.
9. Persico M, De Marino F, Russo GD, et al. Effcacy of lamivu-dine to prevent hepatitis reactivation in hepatitis B virus- infected patients treated for non-Hodgkin lymphoma. Blood 2002;99:724-5.
10. Li YH, He YF, Jiang WQ, et al. Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma. Cancer 2006;106:1320-1325.
11. Kim JS, Hahn JS, Park SY, et al. Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma. Yonsei Med J 2007;48:78-89.
12. Katz LH, Fraser A, Gafter-Gvili, Leibovici L, Tur-Kaspa R. Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis. J Viral Hepat 2008;15:89-102.
13. Weinbaum CM, Williams I, Mast EE, et al. Recommendations for identifcation and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008;57:1-20.
14. Sherman M, Shafran S, Burak K, et al. Management of chronic hepatitis B: consensus guidelines. Can J Gastroenterol 2007;21(suppl C):5C-24C.
15. Guinane CS, Sikes JI, Wilson RK. Using the pd sa cycle to standardize a quality assurance program in a quality improvement driven environment. Jt Comm J Qual Improv 1994;20:696-705.
16. Nigashiyama H, Harabayashi T, Shinohara N, Chuma M, Hige S, Nonomura K. Reactivation of hepatitis in a bladder cancer patient receiving chemotherapy. Int Urol Nephrol 2007;39:461-3.
17. Öksüzoglu B, Kilickap S, Yalcin S. Reactivation of hepatitis B virus infection in pancreatic cancer: a case report. Jpn J Clin Oncol 2002;32:543-5.
18. Mok TS, Zee B, Chan AT, et al. A phase ii study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma. Cancer 2000;89:543-50.
19. Yeo W, Chan PK, Hui P, et al. Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study. J Med Virol 2003;70:553-61.
20. Sladek RM, Bond MJ, Huynh LT, Chew DP, Phillips PA. Thinking styles and doctors' knowledge and behaviors relating to acute coronary syndromes guidelines. Implement Sci 2008;3:23.
21. Sladek RM, Bond MJ, Phillips PA. Why don't doctors wash their hands? A correlational study of thinking styles and hand hygiene. Am J Infect Control 2008;36:399-406.
22. Taylor VM, Yasui Y, Burke N, et al. Hepatitis B testing among Vietnamese American men. Cancer Detect Prev 2004;28:170-7.
23. Wu CA, Lin SY, So SK, Chang ET. Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California. Asian Pac J Cancer Prev 2007;8:127-134.